The new members of the Advisory Committee on Immunization Practices began their tenure Wednesday by shifting the posture of ...

President Donald Trump’s One Big Beautiful Bill Act, sprawling legislation to extend his tax cuts and enact much of his ...

PatientPoint’s Project Futurama featured discussions on staying relevant in a digital age dominated by virtual healthcare and ...

The long-term health care industry is facing a double whammy from President Donald Trump’s crackdown on immigrants and the ...

Nearly seven months after the fatal shooting of an insurance CEO in New York drew widespread attention to health insurers’ ...

Yet despite the increased efforts from various health brands to raise awareness around menopause, both HCPs and patients ...

Millions of people are expected to lose access to Medicaid and Affordable Care Act marketplace health insurance plans if federal lawmakers approve the One Big Beautiful Bill Act, President Donald ...

Merck announced ACIP voted to recommend Enflosnia (clesrovimab-cfor) as a treatment option for RSV in infants younger than 8 months of age who are born during or entering their first RSV season.

Earlier this week, the pharma giant publicly accused Hims & Hers of “deceptive” marketing that is putting patient safety at risk.

What does it take to secure, plan and execute a main stage presentation at Cannes?

Millions of Americans who have waited decades for fast internet connections will keep waiting after the Trump administration ...

Historic changes are afoot for pharma as China gains ground on U.S. production. The pharma industry is projected to see ...